[External quality assurance of inpatient treatment in schizophrenia. results of a multicenter study]

Nervenarzt. 2000 May;71(5):364-72. doi: 10.1007/s001150050570.
[Article in German]

Abstract

Due to legal regulations, external quality assurance is mandatory in Germany. Supported by the German Health Ministry (BMG), we present the results of a multicenter study in four hospitals with different structures on 1042 inpatients with the tracer diagnosis of schizophrenia (ICD 10). We defined disease-specific indicators of structure, process, and outcome quality, developed an assessment instrument, and implemented a feedback system for quality comparison. The resulting quality profiles are useful as a starting point for internal quality management.

Publication types

  • Multicenter Study

MeSH terms

  • Acute Disease
  • Antipsychotic Agents / administration & dosage
  • Female
  • Germany
  • Hospitals, University / standards*
  • Hospitals, University / statistics & numerical data
  • Humans
  • Inpatients / statistics & numerical data*
  • Length of Stay
  • Male
  • Outcome and Process Assessment, Health Care / methods*
  • Patient Satisfaction
  • Quality Indicators, Health Care*
  • Recurrence
  • Retrospective Studies
  • Schizophrenia / therapy*
  • Total Quality Management / methods

Substances

  • Antipsychotic Agents